Clinical Trial Search

Primary: Part A: Area Under the Curve From Time Zero to Infinity (AUC[0-inf]) of GSK2982772 240 mg in IR Formulation — 14.355 Hours*microgram per milliliter

Primary: Pharmacokinetics (PK): Insulin Lispro Area Under the Concentration Versus Time Curve (AUC) — 649; 656; 1400; 1450 picomole * hour per liter(pmol*/L) — p=0.5495

Primary: Pharmacokinetics (PK): Insulin Lispro Area Under the Concentration Curve Zero to 10 Hours (AUC 0-10h) Following Administration of Each Treatment Arm — 1930; 1980…

Primary: Pharmacokinetics (PK): Insulin Lispro Area Under the Concentration Curve From Time Zero to 8 Hours (AUC[0-8 Hours]) — 2440; 2430 picomole*hour/liter (pmol*h/L)

Primary: Area Under the Lamotrigine Concentration vs. Time Curve From Sample Time Point 0 Hour to Sample Time Point 144 Hour. — 119966.6; 121969.5 h*ng/mL

Primary: Pharmacokinetics: Insulin Lispro Area Under the Concentration Versus Time Curve (AUC) for Each Treatment Arm — 1430; 1400; 1210; 1170 picomole * hour per Liter (pmol*h/L)

Primary: Pharmacokinetics (PK): Insulin Lispro or Insulin Aspart Area Under the Concentration Curve From Zero to Seven Hours (AUC 0-7h) Following Administration of Each Study Arm…

Primary: Pharmacokinetics: Insulin Lispro Area Under the Concentration Versus Time Curve (AUC) Following LY900014 Administration — 1760; 1800; 2770; 1750 picomole * hour/Liter…

Primary: Pharmacokinetics: Insulin Lispro Area Under the Concentration Curve From Time Zero to 10 Hours(h) (AUC [0-10h]) Following Administration of Each Study Arm — 1690; 1710…

Primary: Maximum Tolerated Dose (MTD), Defined as Maximum Dose at Which the Incidence of Dose Limiting Toxicities (DLTs) During Cycle 1 is Below 20% — 800 mg BID

Primary: Pharmacokinetics (PK): Insulin Lispro Area Under the Concentration Curve From Time Zero to 5 Hours (AUC[0-5h]) (Part A) — 1520; 1830 picomole*hour per liter (pmol*h/L)

Primary: Pharmacokinetics (PK): Insulin Lispro Area Under the Concentration Curve From Time Zero to 5 Hours (AUC[0-5h]) (Part A) — 719; 783 picomole*hour per liter (pmol*h/L)

Primary: Pharmacokinetics (PK): Insulin Lispro Area Under the Concentration Curve From Time Zero to 5 Hours (AUC[0-5h]) — 918; 970; 906; 824 picomole*hour per liter (pmol•h/L)

Primary: Number of Subjects With Injection Site Reactions Month 1 — 0; 0; 0; 1 Participants

Primary: Pharmacokinetics (PK): Insulin Lispro Area Under the Concentration Curve From Time Zero to 8 Hours (AUC[0-8 Hours]) — 2050; 1930 Picomoles*hour/Liter (pmol*h/L)